Original language | English |
---|---|
Pages (from-to) | e72-e74 |
Journal | HIV Medicine |
Volume | 19 |
Issue number | 8 |
DOIs | |
Publication status | Published - Sept 2018 |
Bibliographical note
Funding Information:Funding statement: The HIV in Europe initiative has received project grants from Gilead Sciences, Merck, Pfizer, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. The operational procedures within the initiative include the following, to maintain the autonomy of the initiative: the Steering Committee is the governing body on which sponsors have no representation; data, records, reports, intellectual property rights and know-how generated as result of the initiative shall be deemed vested in and the property of the Steering Committee, represented by the Secretariat CHIP Department of Infectious Diseases, Rigshospitalet. CHIP has received funding from the European Union for the INTEGRATE Joint Action, within the framework of the Third Health Programme, and the Danish National Research Foundation (grant number DNRF126). The funders had no role in the decision to publish or preparation of the manuscript.